nodes	percent_of_prediction	percent_of_DWPC	metapath
Etodolac—PTGS2—head and neck cancer	0.7	1	CbGaD
Etodolac—Lung infiltration—Hydroxyurea—head and neck cancer	0.00418	0.0242	CcSEcCtD
Etodolac—Skin hyperpigmentation—Hydroxyurea—head and neck cancer	0.00329	0.0191	CcSEcCtD
Etodolac—Peptic ulcer—Vinblastine—head and neck cancer	0.00321	0.0186	CcSEcCtD
Etodolac—Rectal haemorrhage—Vinblastine—head and neck cancer	0.00238	0.0138	CcSEcCtD
Etodolac—Skin hyperpigmentation—Fluorouracil—head and neck cancer	0.00237	0.0138	CcSEcCtD
Etodolac—Ulcer—Hydroxyurea—head and neck cancer	0.00207	0.012	CcSEcCtD
Etodolac—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00207	0.012	CcSEcCtD
Etodolac—Heartburn—Fluorouracil—head and neck cancer	0.00205	0.0119	CcSEcCtD
Etodolac—Photophobia—Vinblastine—head and neck cancer	0.00202	0.0117	CcSEcCtD
Etodolac—Skin exfoliation—Hydroxyurea—head and neck cancer	0.00187	0.0109	CcSEcCtD
Etodolac—Blood urea increased—Hydroxyurea—head and neck cancer	0.00185	0.0107	CcSEcCtD
Etodolac—Rash maculo-papular—Hydroxyurea—head and neck cancer	0.00178	0.0103	CcSEcCtD
Etodolac—Deafness—Vinblastine—head and neck cancer	0.00174	0.0101	CcSEcCtD
Etodolac—Skin hyperpigmentation—Docetaxel—head and neck cancer	0.00171	0.00993	CcSEcCtD
Etodolac—Cerebrovascular accident—Vinblastine—head and neck cancer	0.00159	0.00923	CcSEcCtD
Etodolac—Hepatic failure—Hydroxyurea—head and neck cancer	0.00158	0.00918	CcSEcCtD
Etodolac—Ulcer—Fluorouracil—head and neck cancer	0.00149	0.00865	CcSEcCtD
Etodolac—Dermatitis bullous—Hydroxyurea—head and neck cancer	0.00149	0.00863	CcSEcCtD
Etodolac—Heartburn—Docetaxel—head and neck cancer	0.00148	0.00858	CcSEcCtD
Etodolac—Burning sensation—Docetaxel—head and neck cancer	0.00147	0.0085	CcSEcCtD
Etodolac—Photophobia—Fluorouracil—head and neck cancer	0.00132	0.00768	CcSEcCtD
Etodolac—Oesophagitis—Fluorouracil—head and neck cancer	0.00129	0.00748	CcSEcCtD
Etodolac—Coma—Fluorouracil—head and neck cancer	0.00129	0.00748	CcSEcCtD
Etodolac—Rash maculo-papular—Fluorouracil—head and neck cancer	0.00128	0.00744	CcSEcCtD
Etodolac—Pancytopenia—Vinblastine—head and neck cancer	0.00128	0.00743	CcSEcCtD
Etodolac—Ageusia—Docetaxel—head and neck cancer	0.00126	0.00729	CcSEcCtD
Etodolac—Sepsis—Fluorouracil—head and neck cancer	0.00122	0.0071	CcSEcCtD
Etodolac—Pancreatitis—Hydroxyurea—head and neck cancer	0.00121	0.00699	CcSEcCtD
Etodolac—Acute coronary syndrome—Vinblastine—head and neck cancer	0.00119	0.00687	CcSEcCtD
Etodolac—Myocardial infarction—Vinblastine—head and neck cancer	0.00118	0.00683	CcSEcCtD
Etodolac—Pancytopenia—Hydroxyurea—head and neck cancer	0.00117	0.00677	CcSEcCtD
Etodolac—Photosensitivity—Fluorouracil—head and neck cancer	0.00117	0.00676	CcSEcCtD
Etodolac—Dysuria—Hydroxyurea—head and neck cancer	0.00115	0.00667	CcSEcCtD
Etodolac—Neutropenia—Hydroxyurea—head and neck cancer	0.00115	0.00667	CcSEcCtD
Etodolac—Agranulocytosis—Vinblastine—head and neck cancer	0.00112	0.00651	CcSEcCtD
Etodolac—Oliguria—Docetaxel—head and neck cancer	0.0011	0.00641	CcSEcCtD
Etodolac—Haemoglobin—Vinblastine—head and neck cancer	0.00108	0.00629	CcSEcCtD
Etodolac—Haemorrhage—Vinblastine—head and neck cancer	0.00108	0.00626	CcSEcCtD
Etodolac—Dermatitis bullous—Fluorouracil—head and neck cancer	0.00107	0.00621	CcSEcCtD
Etodolac—Pharyngitis—Vinblastine—head and neck cancer	0.00107	0.00621	CcSEcCtD
Etodolac—Hearing impaired—Docetaxel—head and neck cancer	0.00107	0.0062	CcSEcCtD
Etodolac—Stomatitis—Hydroxyurea—head and neck cancer	0.00107	0.0062	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Fluorouracil—head and neck cancer	0.00102	0.00594	CcSEcCtD
Etodolac—Haemoglobin—Hydroxyurea—head and neck cancer	0.000989	0.00574	CcSEcCtD
Etodolac—Haemorrhage—Hydroxyurea—head and neck cancer	0.000984	0.00571	CcSEcCtD
Etodolac—Hallucination—Hydroxyurea—head and neck cancer	0.000979	0.00568	CcSEcCtD
Etodolac—Colitis—Docetaxel—head and neck cancer	0.000978	0.00567	CcSEcCtD
Etodolac—Irritability—Fluorouracil—head and neck cancer	0.000977	0.00567	CcSEcCtD
Etodolac—Skin exfoliation—Docetaxel—head and neck cancer	0.000972	0.00564	CcSEcCtD
Etodolac—Alopecia—Vinblastine—head and neck cancer	0.000954	0.00553	CcSEcCtD
Etodolac—Oesophagitis—Docetaxel—head and neck cancer	0.00093	0.0054	CcSEcCtD
Etodolac—Sepsis—Docetaxel—head and neck cancer	0.000884	0.00512	CcSEcCtD
Etodolac—Chills—Hydroxyurea—head and neck cancer	0.000883	0.00512	CcSEcCtD
Etodolac—Eosinophilia—Fluorouracil—head and neck cancer	0.000876	0.00508	CcSEcCtD
Etodolac—Ill-defined disorder—Vinblastine—head and neck cancer	0.000872	0.00505	CcSEcCtD
Etodolac—Alopecia—Hydroxyurea—head and neck cancer	0.00087	0.00504	CcSEcCtD
Etodolac—Anaemia—Vinblastine—head and neck cancer	0.000868	0.00504	CcSEcCtD
Etodolac—Malaise—Vinblastine—head and neck cancer	0.000847	0.00491	CcSEcCtD
Etodolac—Vertigo—Vinblastine—head and neck cancer	0.000844	0.00489	CcSEcCtD
Etodolac—Leukopenia—Vinblastine—head and neck cancer	0.000841	0.00488	CcSEcCtD
Etodolac—Pancytopenia—Fluorouracil—head and neck cancer	0.00084	0.00487	CcSEcCtD
Etodolac—Deafness—Docetaxel—head and neck cancer	0.000826	0.00479	CcSEcCtD
Etodolac—Hepatic failure—Docetaxel—head and neck cancer	0.000822	0.00477	CcSEcCtD
Etodolac—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000815	0.00473	CcSEcCtD
Etodolac—Convulsion—Vinblastine—head and neck cancer	0.000814	0.00472	CcSEcCtD
Etodolac—Hypertension—Vinblastine—head and neck cancer	0.000811	0.0047	CcSEcCtD
Etodolac—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000808	0.00468	CcSEcCtD
Etodolac—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000795	0.00461	CcSEcCtD
Etodolac—Pneumonia—Fluorouracil—head and neck cancer	0.000794	0.0046	CcSEcCtD
Etodolac—Anaemia—Hydroxyurea—head and neck cancer	0.000792	0.00459	CcSEcCtD
Etodolac—Discomfort—Vinblastine—head and neck cancer	0.00079	0.00458	CcSEcCtD
Etodolac—Visual disturbance—Docetaxel—head and neck cancer	0.00078	0.00452	CcSEcCtD
Etodolac—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000778	0.00451	CcSEcCtD
Etodolac—Renal impairment—Docetaxel—head and neck cancer	0.000777	0.0045	CcSEcCtD
Etodolac—Myocardial infarction—Fluorouracil—head and neck cancer	0.000774	0.00449	CcSEcCtD
Etodolac—Dermatitis bullous—Docetaxel—head and neck cancer	0.000773	0.00448	CcSEcCtD
Etodolac—Malaise—Hydroxyurea—head and neck cancer	0.000773	0.00448	CcSEcCtD
Etodolac—Stomatitis—Fluorouracil—head and neck cancer	0.000769	0.00446	CcSEcCtD
Etodolac—Conjunctivitis—Fluorouracil—head and neck cancer	0.000767	0.00445	CcSEcCtD
Etodolac—Leukopenia—Hydroxyurea—head and neck cancer	0.000767	0.00445	CcSEcCtD
Etodolac—Thrombocytopenia—Vinblastine—head and neck cancer	0.000751	0.00435	CcSEcCtD
Etodolac—Convulsion—Hydroxyurea—head and neck cancer	0.000742	0.0043	CcSEcCtD
Etodolac—Sinusitis—Fluorouracil—head and neck cancer	0.00074	0.00429	CcSEcCtD
Etodolac—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000739	0.00429	CcSEcCtD
Etodolac—Agranulocytosis—Fluorouracil—head and neck cancer	0.000736	0.00427	CcSEcCtD
Etodolac—Anorexia—Vinblastine—head and neck cancer	0.000731	0.00424	CcSEcCtD
Etodolac—Discomfort—Hydroxyurea—head and neck cancer	0.000721	0.00418	CcSEcCtD
Etodolac—Haemoglobin—Fluorouracil—head and neck cancer	0.000712	0.00413	CcSEcCtD
Etodolac—Rhinitis—Fluorouracil—head and neck cancer	0.00071	0.00412	CcSEcCtD
Etodolac—Haemorrhage—Fluorouracil—head and neck cancer	0.000708	0.00411	CcSEcCtD
Etodolac—Pharyngitis—Fluorouracil—head and neck cancer	0.000703	0.00408	CcSEcCtD
Etodolac—Oedema—Hydroxyurea—head and neck cancer	0.000699	0.00405	CcSEcCtD
Etodolac—Infection—Hydroxyurea—head and neck cancer	0.000695	0.00403	CcSEcCtD
Etodolac—Paraesthesia—Vinblastine—head and neck cancer	0.000688	0.00399	CcSEcCtD
Etodolac—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000685	0.00397	CcSEcCtD
Etodolac—Abdominal pain upper—Docetaxel—head and neck cancer	0.000675	0.00391	CcSEcCtD
Etodolac—Anorexia—Hydroxyurea—head and neck cancer	0.000666	0.00387	CcSEcCtD
Etodolac—Decreased appetite—Vinblastine—head and neck cancer	0.000666	0.00387	CcSEcCtD
Etodolac—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000666	0.00386	CcSEcCtD
Etodolac—Pain—Vinblastine—head and neck cancer	0.000656	0.0038	CcSEcCtD
Etodolac—Constipation—Vinblastine—head and neck cancer	0.000656	0.0038	CcSEcCtD
Etodolac—Arrhythmia—Fluorouracil—head and neck cancer	0.000633	0.00367	CcSEcCtD
Etodolac—Feeling abnormal—Vinblastine—head and neck cancer	0.000632	0.00366	CcSEcCtD
Etodolac—Bronchospasm—Docetaxel—head and neck cancer	0.000628	0.00364	CcSEcCtD
Etodolac—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000627	0.00364	CcSEcCtD
Etodolac—Alopecia—Fluorouracil—head and neck cancer	0.000626	0.00363	CcSEcCtD
Etodolac—Dyspnoea—Hydroxyurea—head and neck cancer	0.000623	0.00362	CcSEcCtD
Etodolac—Somnolence—Hydroxyurea—head and neck cancer	0.000622	0.0036	CcSEcCtD
Etodolac—Dyspepsia—Hydroxyurea—head and neck cancer	0.000615	0.00357	CcSEcCtD
Etodolac—Decreased appetite—Hydroxyurea—head and neck cancer	0.000608	0.00352	CcSEcCtD
Etodolac—Pancytopenia—Docetaxel—head and neck cancer	0.000607	0.00352	CcSEcCtD
Etodolac—Abdominal pain—Vinblastine—head and neck cancer	0.000606	0.00351	CcSEcCtD
Etodolac—Fatigue—Hydroxyurea—head and neck cancer	0.000603	0.0035	CcSEcCtD
Etodolac—Constipation—Hydroxyurea—head and neck cancer	0.000598	0.00347	CcSEcCtD
Etodolac—Pain—Hydroxyurea—head and neck cancer	0.000598	0.00347	CcSEcCtD
Etodolac—Neutropenia—Docetaxel—head and neck cancer	0.000597	0.00346	CcSEcCtD
Etodolac—Vision blurred—Fluorouracil—head and neck cancer	0.000581	0.00337	CcSEcCtD
Etodolac—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000576	0.00334	CcSEcCtD
Etodolac—Pneumonia—Docetaxel—head and neck cancer	0.000573	0.00332	CcSEcCtD
Etodolac—Anaemia—Fluorouracil—head and neck cancer	0.00057	0.00331	CcSEcCtD
Etodolac—Hypersensitivity—Vinblastine—head and neck cancer	0.000565	0.00328	CcSEcCtD
Etodolac—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000565	0.00327	CcSEcCtD
Etodolac—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000561	0.00326	CcSEcCtD
Etodolac—Renal failure—Docetaxel—head and neck cancer	0.00056	0.00325	CcSEcCtD
Etodolac—Myocardial infarction—Docetaxel—head and neck cancer	0.000558	0.00324	CcSEcCtD
Etodolac—Jaundice—Docetaxel—head and neck cancer	0.000555	0.00322	CcSEcCtD
Etodolac—Stomatitis—Docetaxel—head and neck cancer	0.000555	0.00322	CcSEcCtD
Etodolac—Conjunctivitis—Docetaxel—head and neck cancer	0.000554	0.00321	CcSEcCtD
Etodolac—Body temperature increased—Hydroxyurea—head and neck cancer	0.000553	0.00321	CcSEcCtD
Etodolac—Leukopenia—Fluorouracil—head and neck cancer	0.000552	0.0032	CcSEcCtD
Etodolac—Asthenia—Vinblastine—head and neck cancer	0.00055	0.00319	CcSEcCtD
Etodolac—Convulsion—Fluorouracil—head and neck cancer	0.000534	0.0031	CcSEcCtD
Etodolac—Agranulocytosis—Docetaxel—head and neck cancer	0.000532	0.00308	CcSEcCtD
Etodolac—Myalgia—Fluorouracil—head and neck cancer	0.000525	0.00304	CcSEcCtD
Etodolac—Diarrhoea—Vinblastine—head and neck cancer	0.000525	0.00304	CcSEcCtD
Etodolac—Discomfort—Fluorouracil—head and neck cancer	0.000519	0.00301	CcSEcCtD
Etodolac—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000515	0.00299	CcSEcCtD
Etodolac—Haemoglobin—Docetaxel—head and neck cancer	0.000514	0.00298	CcSEcCtD
Etodolac—Rhinitis—Docetaxel—head and neck cancer	0.000513	0.00297	CcSEcCtD
Etodolac—Hepatitis—Docetaxel—head and neck cancer	0.000511	0.00297	CcSEcCtD
Etodolac—Haemorrhage—Docetaxel—head and neck cancer	0.000511	0.00297	CcSEcCtD
Etodolac—Confusional state—Fluorouracil—head and neck cancer	0.000507	0.00294	CcSEcCtD
Etodolac—Pharyngitis—Docetaxel—head and neck cancer	0.000507	0.00294	CcSEcCtD
Etodolac—Dizziness—Vinblastine—head and neck cancer	0.000507	0.00294	CcSEcCtD
Etodolac—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000503	0.00292	CcSEcCtD
Etodolac—Oedema—Fluorouracil—head and neck cancer	0.000503	0.00292	CcSEcCtD
Etodolac—Asthenia—Hydroxyurea—head and neck cancer	0.000502	0.00291	CcSEcCtD
Etodolac—Infection—Fluorouracil—head and neck cancer	0.0005	0.0029	CcSEcCtD
Etodolac—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000493	0.00286	CcSEcCtD
Etodolac—Visual impairment—Docetaxel—head and neck cancer	0.000493	0.00286	CcSEcCtD
Etodolac—Tachycardia—Fluorouracil—head and neck cancer	0.000491	0.00285	CcSEcCtD
Etodolac—Vomiting—Vinblastine—head and neck cancer	0.000487	0.00283	CcSEcCtD
Etodolac—Erythema multiforme—Docetaxel—head and neck cancer	0.000483	0.0028	CcSEcCtD
Etodolac—Headache—Vinblastine—head and neck cancer	0.00048	0.00279	CcSEcCtD
Etodolac—Anorexia—Fluorouracil—head and neck cancer	0.00048	0.00278	CcSEcCtD
Etodolac—Diarrhoea—Hydroxyurea—head and neck cancer	0.000478	0.00277	CcSEcCtD
Etodolac—Flushing—Docetaxel—head and neck cancer	0.000475	0.00275	CcSEcCtD
Etodolac—Hypotension—Fluorouracil—head and neck cancer	0.00047	0.00273	CcSEcCtD
Etodolac—Dizziness—Hydroxyurea—head and neck cancer	0.000462	0.00268	CcSEcCtD
Etodolac—Chills—Docetaxel—head and neck cancer	0.000459	0.00266	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000459	0.00266	CcSEcCtD
Etodolac—Arrhythmia—Docetaxel—head and neck cancer	0.000457	0.00265	CcSEcCtD
Etodolac—Nausea—Vinblastine—head and neck cancer	0.000455	0.00264	CcSEcCtD
Etodolac—Insomnia—Fluorouracil—head and neck cancer	0.000455	0.00264	CcSEcCtD
Etodolac—Paraesthesia—Fluorouracil—head and neck cancer	0.000452	0.00262	CcSEcCtD
Etodolac—Alopecia—Docetaxel—head and neck cancer	0.000452	0.00262	CcSEcCtD
Etodolac—Dyspnoea—Fluorouracil—head and neck cancer	0.000449	0.0026	CcSEcCtD
Etodolac—Somnolence—Fluorouracil—head and neck cancer	0.000447	0.00259	CcSEcCtD
Etodolac—Vomiting—Hydroxyurea—head and neck cancer	0.000445	0.00258	CcSEcCtD
Etodolac—Dyspepsia—Fluorouracil—head and neck cancer	0.000443	0.00257	CcSEcCtD
Etodolac—Rash—Hydroxyurea—head and neck cancer	0.000441	0.00256	CcSEcCtD
Etodolac—Dermatitis—Hydroxyurea—head and neck cancer	0.00044	0.00255	CcSEcCtD
Etodolac—Headache—Hydroxyurea—head and neck cancer	0.000438	0.00254	CcSEcCtD
Etodolac—Decreased appetite—Fluorouracil—head and neck cancer	0.000438	0.00254	CcSEcCtD
Etodolac—Dysgeusia—Docetaxel—head and neck cancer	0.000436	0.00253	CcSEcCtD
Etodolac—Pain—Fluorouracil—head and neck cancer	0.00043	0.0025	CcSEcCtD
Etodolac—Nausea—Hydroxyurea—head and neck cancer	0.000415	0.00241	CcSEcCtD
Etodolac—Feeling abnormal—Fluorouracil—head and neck cancer	0.000415	0.00241	CcSEcCtD
Etodolac—Anaemia—Docetaxel—head and neck cancer	0.000411	0.00239	CcSEcCtD
Etodolac—Urticaria—Fluorouracil—head and neck cancer	0.0004	0.00232	CcSEcCtD
Etodolac—Syncope—Docetaxel—head and neck cancer	0.000399	0.00231	CcSEcCtD
Etodolac—Leukopenia—Docetaxel—head and neck cancer	0.000398	0.00231	CcSEcCtD
Etodolac—Body temperature increased—Fluorouracil—head and neck cancer	0.000398	0.00231	CcSEcCtD
Etodolac—Palpitations—Docetaxel—head and neck cancer	0.000393	0.00228	CcSEcCtD
Etodolac—Loss of consciousness—Docetaxel—head and neck cancer	0.000391	0.00227	CcSEcCtD
Etodolac—Convulsion—Docetaxel—head and neck cancer	0.000386	0.00224	CcSEcCtD
Etodolac—Hypertension—Docetaxel—head and neck cancer	0.000384	0.00223	CcSEcCtD
Etodolac—Myalgia—Docetaxel—head and neck cancer	0.000379	0.0022	CcSEcCtD
Etodolac—Arthralgia—Docetaxel—head and neck cancer	0.000379	0.0022	CcSEcCtD
Etodolac—Hypersensitivity—Fluorouracil—head and neck cancer	0.000371	0.00215	CcSEcCtD
Etodolac—Dry mouth—Docetaxel—head and neck cancer	0.000371	0.00215	CcSEcCtD
Etodolac—Confusional state—Docetaxel—head and neck cancer	0.000366	0.00212	CcSEcCtD
Etodolac—Oedema—Docetaxel—head and neck cancer	0.000363	0.00211	CcSEcCtD
Etodolac—Anaphylactic shock—Docetaxel—head and neck cancer	0.000363	0.00211	CcSEcCtD
Etodolac—Infection—Docetaxel—head and neck cancer	0.000361	0.00209	CcSEcCtD
Etodolac—Shock—Docetaxel—head and neck cancer	0.000357	0.00207	CcSEcCtD
Etodolac—Pruritus—Fluorouracil—head and neck cancer	0.000356	0.00206	CcSEcCtD
Etodolac—Thrombocytopenia—Docetaxel—head and neck cancer	0.000356	0.00206	CcSEcCtD
Etodolac—Tachycardia—Docetaxel—head and neck cancer	0.000355	0.00206	CcSEcCtD
Etodolac—Anorexia—Docetaxel—head and neck cancer	0.000346	0.00201	CcSEcCtD
Etodolac—Diarrhoea—Fluorouracil—head and neck cancer	0.000344	0.002	CcSEcCtD
Etodolac—Hypotension—Docetaxel—head and neck cancer	0.000339	0.00197	CcSEcCtD
Etodolac—Dizziness—Fluorouracil—head and neck cancer	0.000333	0.00193	CcSEcCtD
Etodolac—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000331	0.00192	CcSEcCtD
Etodolac—Insomnia—Docetaxel—head and neck cancer	0.000329	0.00191	CcSEcCtD
Etodolac—Paraesthesia—Docetaxel—head and neck cancer	0.000326	0.00189	CcSEcCtD
Etodolac—Dyspnoea—Docetaxel—head and neck cancer	0.000324	0.00188	CcSEcCtD
Etodolac—Somnolence—Docetaxel—head and neck cancer	0.000323	0.00187	CcSEcCtD
Etodolac—Vomiting—Fluorouracil—head and neck cancer	0.00032	0.00186	CcSEcCtD
Etodolac—Dyspepsia—Docetaxel—head and neck cancer	0.00032	0.00185	CcSEcCtD
Etodolac—Rash—Fluorouracil—head and neck cancer	0.000317	0.00184	CcSEcCtD
Etodolac—Dermatitis—Fluorouracil—head and neck cancer	0.000317	0.00184	CcSEcCtD
Etodolac—Decreased appetite—Docetaxel—head and neck cancer	0.000316	0.00183	CcSEcCtD
Etodolac—Headache—Fluorouracil—head and neck cancer	0.000315	0.00183	CcSEcCtD
Etodolac—Fatigue—Docetaxel—head and neck cancer	0.000313	0.00182	CcSEcCtD
Etodolac—Constipation—Docetaxel—head and neck cancer	0.000311	0.0018	CcSEcCtD
Etodolac—Pain—Docetaxel—head and neck cancer	0.000311	0.0018	CcSEcCtD
Etodolac—Feeling abnormal—Docetaxel—head and neck cancer	0.000299	0.00174	CcSEcCtD
Etodolac—ALB—Folate Metabolism—SOD2—head and neck cancer	0.000299	0.00236	CbGpPWpGaD
Etodolac—Nausea—Fluorouracil—head and neck cancer	0.000299	0.00173	CcSEcCtD
Etodolac—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000297	0.00172	CcSEcCtD
Etodolac—PTGS2—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000294	0.00231	CbGpPWpGaD
Etodolac—CYP2C9—Arachidonic acid metabolism—GPX1—head and neck cancer	0.000292	0.0023	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—RARB—head and neck cancer	0.000292	0.0023	CbGpPWpGaD
Etodolac—CYP2C9—Arachidonic acid metabolism—CYP1A1—head and neck cancer	0.000289	0.00227	CbGpPWpGaD
Etodolac—RXRA—Biological oxidations—CYP1A1—head and neck cancer	0.000288	0.00227	CbGpPWpGaD
Etodolac—Body temperature increased—Docetaxel—head and neck cancer	0.000287	0.00167	CcSEcCtD
Etodolac—Abdominal pain—Docetaxel—head and neck cancer	0.000287	0.00167	CcSEcCtD
Etodolac—ALB—Folate Metabolism—GPX1—head and neck cancer	0.000286	0.00225	CbGpPWpGaD
Etodolac—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—head and neck cancer	0.000285	0.00224	CbGpPWpGaD
Etodolac—RXRA—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000284	0.00224	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000283	0.00223	CbGpPWpGaD
Etodolac—PTGS2—Selenium Micronutrient Network—GPX1—head and neck cancer	0.00028	0.00221	CbGpPWpGaD
Etodolac—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000278	0.00219	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—UROD—head and neck cancer	0.000272	0.00214	CbGpPWpGaD
Etodolac—Hypersensitivity—Docetaxel—head and neck cancer	0.000268	0.00155	CcSEcCtD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—RAD51—head and neck cancer	0.000265	0.00209	CbGpPWpGaD
Etodolac—UGT1A9—Biological oxidations—GSTM1—head and neck cancer	0.000265	0.00208	CbGpPWpGaD
Etodolac—UGT1A9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000261	0.00206	CbGpPWpGaD
Etodolac—Asthenia—Docetaxel—head and neck cancer	0.000261	0.00151	CcSEcCtD
Etodolac—RXRA—Generic Transcription Pathway—RARB—head and neck cancer	0.000257	0.00202	CbGpPWpGaD
Etodolac—Pruritus—Docetaxel—head and neck cancer	0.000257	0.00149	CcSEcCtD
Etodolac—RXRA—Metabolism—UROD—head and neck cancer	0.000253	0.00199	CbGpPWpGaD
Etodolac—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—head and neck cancer	0.000252	0.00198	CbGpPWpGaD
Etodolac—UGT1A9—Biological oxidations—CYP1A1—head and neck cancer	0.000251	0.00198	CbGpPWpGaD
Etodolac—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP1A1—head and neck cancer	0.00025	0.00197	CbGpPWpGaD
Etodolac—SLC22A6—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.000249	0.00196	CbGpPWpGaD
Etodolac—Diarrhoea—Docetaxel—head and neck cancer	0.000249	0.00144	CcSEcCtD
Etodolac—UGT1A9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000247	0.00195	CbGpPWpGaD
Etodolac—CYP2C9—Oxidation by Cytochrome P450—CYP1A1—head and neck cancer	0.000246	0.00194	CbGpPWpGaD
Etodolac—UGT1A9—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—head and neck cancer	0.000242	0.00191	CbGpPWpGaD
Etodolac—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—head and neck cancer	0.00024	0.00189	CbGpPWpGaD
Etodolac—Dizziness—Docetaxel—head and neck cancer	0.00024	0.00139	CcSEcCtD
Etodolac—ALB—Selenium Micronutrient Network—SOD2—head and neck cancer	0.000238	0.00187	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—YAP1—head and neck cancer	0.000234	0.00184	CbGpPWpGaD
Etodolac—Vomiting—Docetaxel—head and neck cancer	0.000231	0.00134	CcSEcCtD
Etodolac—CYP2C9—Biological oxidations—NAT2—head and neck cancer	0.00023	0.00181	CbGpPWpGaD
Etodolac—Rash—Docetaxel—head and neck cancer	0.000229	0.00133	CcSEcCtD
Etodolac—Dermatitis—Docetaxel—head and neck cancer	0.000229	0.00133	CcSEcCtD
Etodolac—Headache—Docetaxel—head and neck cancer	0.000228	0.00132	CcSEcCtD
Etodolac—ALB—Selenium Micronutrient Network—GPX1—head and neck cancer	0.000227	0.00179	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—NAT2—head and neck cancer	0.000227	0.00178	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—UROD—head and neck cancer	0.000221	0.00174	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—head and neck cancer	0.000218	0.00172	CbGpPWpGaD
Etodolac—PTGS1—Biological oxidations—GSTM1—head and neck cancer	0.000216	0.0017	CbGpPWpGaD
Etodolac—Nausea—Docetaxel—head and neck cancer	0.000216	0.00125	CcSEcCtD
Etodolac—PTGS1—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000208	0.00164	CbGpPWpGaD
Etodolac—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—head and neck cancer	0.000205	0.00162	CbGpPWpGaD
Etodolac—PTGS1—Biological oxidations—CYP1A1—head and neck cancer	0.000205	0.00161	CbGpPWpGaD
Etodolac—CYP2C9—Phase 1 - Functionalization of compounds—CYP1A1—head and neck cancer	0.000202	0.00159	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—MAPK1—head and neck cancer	0.000197	0.00155	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—EGFR—head and neck cancer	0.000197	0.00155	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000197	0.00155	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000193	0.00152	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—BCL2—head and neck cancer	0.00018	0.00142	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—UROD—head and neck cancer	0.00018	0.00142	CbGpPWpGaD
Etodolac—CYP2C9—Arachidonic acid metabolism—PTGS2—head and neck cancer	0.000172	0.00135	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000171	0.00135	CbGpPWpGaD
Etodolac—RXRA—Adipogenesis—STAT3—head and neck cancer	0.000167	0.00132	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	0.000166	0.00131	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TYMS—head and neck cancer	0.000159	0.00125	CbGpPWpGaD
Etodolac—PTGS2—Aryl Hydrocarbon Receptor—HRAS—head and neck cancer	0.000158	0.00124	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PTGS2—head and neck cancer	0.000158	0.00124	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—IL2—head and neck cancer	0.000156	0.00123	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—CCND1—head and neck cancer	0.000155	0.00122	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—UROD—head and neck cancer	0.000143	0.00112	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	0.000142	0.00112	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.00014	0.0011	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	0.000137	0.00108	CbGpPWpGaD
Etodolac—ALB—Selenium Micronutrient Network—PTGS2—head and neck cancer	0.000134	0.00105	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—NAT2—head and neck cancer	0.000133	0.00104	CbGpPWpGaD
Etodolac—ALB—Transmembrane transport of small molecules—ATP7B—head and neck cancer	0.00013	0.00102	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	0.000124	0.000977	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—RARB—head and neck cancer	0.000124	0.000974	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—IL2—head and neck cancer	0.000121	0.000953	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—CCND1—head and neck cancer	0.000118	0.000929	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	0.000117	0.000924	CbGpPWpGaD
Etodolac—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—head and neck cancer	0.000117	0.00092	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—DPYD—head and neck cancer	0.000116	0.000916	CbGpPWpGaD
Etodolac—ALB—Metabolism—UROD—head and neck cancer	0.000116	0.00091	CbGpPWpGaD
Etodolac—ALB—Platelet degranulation—VEGFA—head and neck cancer	0.000114	0.000894	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—GSTM1—head and neck cancer	0.000113	0.000893	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—NAT2—head and neck cancer	0.000113	0.000888	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—YAP1—head and neck cancer	0.000113	0.000886	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—GSTM1—head and neck cancer	0.000112	0.000881	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	0.000112	0.00088	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	0.000112	0.000879	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	0.000112	0.000879	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	0.000111	0.000872	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	0.000111	0.000871	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—YAP1—head and neck cancer	0.00011	0.000869	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—head and neck cancer	0.000109	0.000858	CbGpPWpGaD
Etodolac—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—head and neck cancer	0.000108	0.000852	CbGpPWpGaD
Etodolac—CYP2C9—Biological oxidations—CYP1A1—head and neck cancer	0.000108	0.000847	CbGpPWpGaD
Etodolac—CYP2C9—Metapathway biotransformation—CYP1A1—head and neck cancer	0.000106	0.000835	CbGpPWpGaD
Etodolac—RXRA—Generic Transcription Pathway—NOTCH1—head and neck cancer	0.000105	0.00083	CbGpPWpGaD
Etodolac—RXRA—Metabolism—NAT2—head and neck cancer	0.000105	0.000828	CbGpPWpGaD
Etodolac—ALB—Folate Metabolism—TP53—head and neck cancer	0.0001	0.000788	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—NOTCH1—head and neck cancer	9.92e-05	0.000781	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—DPYD—head and neck cancer	9.89e-05	0.000779	CbGpPWpGaD
Etodolac—PTGS2—C-MYB transcription factor network—HRAS—head and neck cancer	9.75e-05	0.000768	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	9.73e-05	0.000766	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MAPK3—head and neck cancer	9.73e-05	0.000766	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	9.69e-05	0.000763	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	9.64e-05	0.000759	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—UROD—head and neck cancer	9.46e-05	0.000745	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—YAP1—head and neck cancer	9.39e-05	0.000739	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	9.38e-05	0.000738	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—head and neck cancer	9.35e-05	0.000736	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—MAPK1—head and neck cancer	9.26e-05	0.000729	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—EGFR—head and neck cancer	9.25e-05	0.000729	CbGpPWpGaD
Etodolac—RXRA—Metabolism—DPYD—head and neck cancer	9.23e-05	0.000726	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—NAT2—head and neck cancer	9.17e-05	0.000722	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	8.97e-05	0.000706	CbGpPWpGaD
Etodolac—RXRA—Metabolism—YAP1—head and neck cancer	8.75e-05	0.000689	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—DPYD—head and neck cancer	8.04e-05	0.000633	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—head and neck cancer	8.02e-05	0.000632	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	7.93e-05	0.000625	CbGpPWpGaD
Etodolac—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	7.92e-05	0.000623	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	7.85e-05	0.000618	CbGpPWpGaD
Etodolac—PTGS2—Spinal Cord Injury—TP53—head and neck cancer	7.77e-05	0.000612	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—head and neck cancer	7.74e-05	0.00061	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—YAP1—head and neck cancer	7.63e-05	0.0006	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—NAT2—head and neck cancer	7.47e-05	0.000588	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	7.34e-05	0.000578	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—head and neck cancer	7e-05	0.000551	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—TYMS—head and neck cancer	6.63e-05	0.000522	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—head and neck cancer	6.62e-05	0.000521	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.58e-05	0.000518	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—DPYD—head and neck cancer	6.55e-05	0.000516	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GSTM1—head and neck cancer	6.55e-05	0.000516	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	6.3e-05	0.000496	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	6.3e-05	0.000496	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	6.3e-05	0.000496	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—GPX1—head and neck cancer	6.27e-05	0.000494	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	6.24e-05	0.000491	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—YAP1—head and neck cancer	6.22e-05	0.000489	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—CYP1A1—head and neck cancer	6.21e-05	0.000489	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—NAT2—head and neck cancer	5.93e-05	0.000467	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—IL2—head and neck cancer	5.93e-05	0.000467	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—VEGFA—head and neck cancer	5.8e-05	0.000457	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—STAT3—head and neck cancer	5.74e-05	0.000452	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.74e-05	0.000452	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	5.73e-05	0.000451	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—TYMS—head and neck cancer	5.64e-05	0.000444	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GSTM1—head and neck cancer	5.57e-05	0.000439	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MAPK3—head and neck cancer	5.49e-05	0.000432	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	5.46e-05	0.00043	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—GPX1—head and neck cancer	5.33e-05	0.00042	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	5.29e-05	0.000416	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—CYP1A1—head and neck cancer	5.28e-05	0.000416	CbGpPWpGaD
Etodolac—RXRA—Metabolism—TYMS—head and neck cancer	5.26e-05	0.000414	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—MAPK1—head and neck cancer	5.22e-05	0.000411	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—EGFR—head and neck cancer	5.22e-05	0.000411	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—DPYD—head and neck cancer	5.2e-05	0.000409	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GSTM1—head and neck cancer	5.2e-05	0.000409	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.1e-05	0.000401	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—NOTCH1—head and neck cancer	5.07e-05	0.000399	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.04e-05	0.000397	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—VEGFA—head and neck cancer	5.04e-05	0.000396	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5e-05	0.000393	CbGpPWpGaD
Etodolac—RXRA—Metabolism—GPX1—head and neck cancer	4.98e-05	0.000392	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—YAP1—head and neck cancer	4.94e-05	0.000389	CbGpPWpGaD
Etodolac—RXRA—Metabolism—CYP1A1—head and neck cancer	4.93e-05	0.000388	CbGpPWpGaD
Etodolac—ALB—Metabolism—NAT2—head and neck cancer	4.8e-05	0.000378	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—MAPK3—head and neck cancer	4.76e-05	0.000375	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	4.67e-05	0.000368	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—TYMS—head and neck cancer	4.58e-05	0.000361	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	4.53e-05	0.000357	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GSTM1—head and neck cancer	4.53e-05	0.000356	CbGpPWpGaD
Etodolac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	4.46e-05	0.000351	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—GPX1—head and neck cancer	4.33e-05	0.000341	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—CYP1A1—head and neck cancer	4.29e-05	0.000338	CbGpPWpGaD
Etodolac—ALB—Metabolism—DPYD—head and neck cancer	4.21e-05	0.000331	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—HRAS—head and neck cancer	4.19e-05	0.00033	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.17e-05	0.000328	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.13e-05	0.000325	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	4.07e-05	0.000321	CbGpPWpGaD
Etodolac—RXRA—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.05e-05	0.000319	CbGpPWpGaD
Etodolac—ALB—Metabolism—YAP1—head and neck cancer	3.99e-05	0.000314	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	3.93e-05	0.00031	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—NAT2—head and neck cancer	3.93e-05	0.000309	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—TYMS—head and neck cancer	3.73e-05	0.000294	CbGpPWpGaD
Etodolac—RXRA—Developmental Biology—AKT1—head and neck cancer	3.7e-05	0.000291	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTGS2—head and neck cancer	3.69e-05	0.000291	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GSTM1—head and neck cancer	3.69e-05	0.000291	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—GPX1—head and neck cancer	3.53e-05	0.000278	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	3.53e-05	0.000278	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—CYP1A1—head and neck cancer	3.5e-05	0.000275	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—DPYD—head and neck cancer	3.44e-05	0.000271	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—YAP1—head and neck cancer	3.27e-05	0.000257	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	3.23e-05	0.000255	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PTEN—head and neck cancer	3.22e-05	0.000254	CbGpPWpGaD
Etodolac—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	3.21e-05	0.000253	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTGS2—head and neck cancer	3.14e-05	0.000247	CbGpPWpGaD
Etodolac—ALB—Hemostasis—IL2—head and neck cancer	3.05e-05	0.00024	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3e-05	0.000236	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—TYMS—head and neck cancer	2.96e-05	0.000233	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GSTM1—head and neck cancer	2.93e-05	0.000231	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTGS2—head and neck cancer	2.93e-05	0.000231	CbGpPWpGaD
Etodolac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.87e-05	0.000226	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—MAPK3—head and neck cancer	2.81e-05	0.000221	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—GPX1—head and neck cancer	2.81e-05	0.000221	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—CYP1A1—head and neck cancer	2.78e-05	0.000219	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PTEN—head and neck cancer	2.74e-05	0.000216	CbGpPWpGaD
Etodolac—PTGS2—Disease—NOTCH1—head and neck cancer	2.66e-05	0.000209	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.62e-05	0.000206	CbGpPWpGaD
Etodolac—ALB—Hemostasis—VEGFA—head and neck cancer	2.6e-05	0.000204	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PTEN—head and neck cancer	2.55e-05	0.000201	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTGS2—head and neck cancer	2.55e-05	0.000201	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.46e-05	0.000193	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MAPK3—head and neck cancer	2.46e-05	0.000193	CbGpPWpGaD
Etodolac—ALB—Metabolism—TYMS—head and neck cancer	2.4e-05	0.000189	CbGpPWpGaD
Etodolac—ALB—Metabolism—GSTM1—head and neck cancer	2.37e-05	0.000187	CbGpPWpGaD
Etodolac—ALB—Hemostasis—MAPK1—head and neck cancer	2.34e-05	0.000184	CbGpPWpGaD
Etodolac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	2.28e-05	0.00018	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—PIK3CA—head and neck cancer	2.27e-05	0.000179	CbGpPWpGaD
Etodolac—ALB—Metabolism—GPX1—head and neck cancer	2.27e-05	0.000179	CbGpPWpGaD
Etodolac—ALB—Metabolism—CYP1A1—head and neck cancer	2.25e-05	0.000177	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PTEN—head and neck cancer	2.23e-05	0.000175	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.14e-05	0.000169	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTGS2—head and neck cancer	2.08e-05	0.000164	CbGpPWpGaD
Etodolac—ALB—Hemostasis—PIK3CA—head and neck cancer	2.03e-05	0.00016	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—TYMS—head and neck cancer	1.96e-05	0.000155	CbGpPWpGaD
Etodolac—ALB—Hemostasis—TP53—head and neck cancer	1.96e-05	0.000154	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GSTM1—head and neck cancer	1.94e-05	0.000153	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—PIK3CA—head and neck cancer	1.93e-05	0.000152	CbGpPWpGaD
Etodolac—RXRA—Gene Expression—AKT1—head and neck cancer	1.89e-05	0.000149	CbGpPWpGaD
Etodolac—ALB—Hemostasis—HRAS—head and neck cancer	1.88e-05	0.000148	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—GPX1—head and neck cancer	1.86e-05	0.000146	CbGpPWpGaD
Etodolac—UGT1A3—Metabolism—AKT1—head and neck cancer	1.86e-05	0.000146	CbGpPWpGaD
Etodolac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.85e-05	0.000145	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.84e-05	0.000145	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PTEN—head and neck cancer	1.81e-05	0.000143	CbGpPWpGaD
Etodolac—RXRA—Metabolism—PIK3CA—head and neck cancer	1.8e-05	0.000142	CbGpPWpGaD
Etodolac—PTGS2—Disease—PTEN—head and neck cancer	1.72e-05	0.000135	CbGpPWpGaD
Etodolac—ALB—Hemostasis—AKT1—head and neck cancer	1.66e-05	0.00013	CbGpPWpGaD
Etodolac—UGT2B7—Metabolism—AKT1—head and neck cancer	1.58e-05	0.000124	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—PIK3CA—head and neck cancer	1.57e-05	0.000124	CbGpPWpGaD
Etodolac—PTGS2—Disease—STAT3—head and neck cancer	1.54e-05	0.000121	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.51e-05	0.000119	CbGpPWpGaD
Etodolac—RXRA—Metabolism—AKT1—head and neck cancer	1.47e-05	0.000116	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAPK3—head and neck cancer	1.47e-05	0.000116	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PTEN—head and neck cancer	1.44e-05	0.000113	CbGpPWpGaD
Etodolac—PTGS2—Disease—MAPK1—head and neck cancer	1.4e-05	0.00011	CbGpPWpGaD
Etodolac—PTGS2—Disease—EGFR—head and neck cancer	1.4e-05	0.00011	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTGS2—head and neck cancer	1.34e-05	0.000105	CbGpPWpGaD
Etodolac—UGT1A9—Metabolism—AKT1—head and neck cancer	1.28e-05	0.000101	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—PIK3CA—head and neck cancer	1.28e-05	0.000101	CbGpPWpGaD
Etodolac—PTGS2—Disease—PIK3CA—head and neck cancer	1.21e-05	9.55e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PTEN—head and neck cancer	1.17e-05	9.17e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—HRAS—head and neck cancer	1.12e-05	8.84e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.09e-05	8.61e-05	CbGpPWpGaD
Etodolac—PTGS1—Metabolism—AKT1—head and neck cancer	1.05e-05	8.23e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—PIK3CA—head and neck cancer	1.02e-05	8e-05	CbGpPWpGaD
Etodolac—PTGS2—Disease—AKT1—head and neck cancer	9.91e-06	7.8e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PTEN—head and neck cancer	9.54e-06	7.51e-05	CbGpPWpGaD
Etodolac—PTGS2—Metabolism—AKT1—head and neck cancer	8.3e-06	6.53e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—PIK3CA—head and neck cancer	8.22e-06	6.47e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—PIK3CA—head and neck cancer	6.73e-06	5.3e-05	CbGpPWpGaD
Etodolac—ALB—Metabolism—AKT1—head and neck cancer	6.72e-06	5.29e-05	CbGpPWpGaD
Etodolac—CYP2C9—Metabolism—AKT1—head and neck cancer	5.5e-06	4.33e-05	CbGpPWpGaD
